The Mirror US on MSN
Commonly prescribed drugs could increase dementia risk by 50%, study finds
The study found that consistent use of certain widely-prescribed medications for bladder disorders, Parkinson's disease, and ...
Medications like Ozempic mimic a naturally occurring hormone called glucagon-like peptide-1, or GLP-1, which helps regulate ...
Patients with Alzheimer's who took a GLP-1 drug improved their memory scores and lost less of their brains.
Morning Overview on MSN
A new drug may stop Alzheimer’s before memory loss starts
Alzheimer’s disease has long been a diagnosis that arrives only after memory begins to fray, by which time brain damage is ...
A new study identifies certain neurotoxins responsible for brain inflammation common to early on-set Alzheimer's disease and ...
Even though Novo Nordisk's GLP-1 failed in Alzheimer's trial, some researchers are cautiously optimistic that obesity and diabetes drugs may have benefits for people with one of the most common forms ...
News-Medical.Net on MSN
Experimental drug targets early toxic amyloid to slow Alzheimer’s disease
An experimental drug developed at Northwestern University has demonstrated further promise as an early intervention for ...
People given the herpes medication valacyclovir actually experienced worse cognitive decline than those given a placebo.
A new drug targets Alzheimer’s at its earliest, most silent stage — before memory loss ever begins. Credit: Shutterstock. A ...
Kinney Drugs is partnering with the Alzheimer's Association to present a free webinar. Attendees will learn the ten early warning signs of Alzheimer's and dementia such as memory loss and a decline in ...
Alzheimer’s disease accounts for 60 to 80% of dementia cases, which is why Dr. Nimat Alam of Texas Tech University Health Sciences Center says early diagnosis and treatment is crucial for better ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results